Navigation Links
Marken Strengthens Clinical Trial Distribution Capabilities
Date:1/10/2012

LONDON, Jan. 10, 2012 /PRNewswire/ -- Marken is pleased to announce that Dr. Andrea Zobel has joined Marken in the new role of Senior Director, CTD Operations.  In this capacity she will assume responsibility for all activities within the growing network of Marken operated Clinical Trial Depots once they are completed and qualified for use and also manage the relationship with their affiliate depot network.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

Dr. Zobel is a biochemist by training and spent her early career in drug development as an assistant professor at the Institute for Pharmacology, Freie Universitat Berlin then as Head of Preclinical Development at ActinoDrug Pharmaceuticals, Henningsdorf.  Since 2004 Andrea has worked for Parexel International building unparalleled experience as Director Clinical Logistics Europe and Head of Global Center of Excellence Clinical Trial Supply both building and running a business with annual revenues in excess of USD 50 million.   She has a deep knowledge of managing strategic partnerships within the pharmaceutical industry, specialist knowledge in managing clinical trials logistics worldwide but particularly within Europe and a passion for professional Project Management. 

"We are excited to welcome Andrea to our team, her expertise and knowledge of the industry further strengthens the market leadership of Marken's Clinical Trial Distribution service line,"  Marken CEO, Wes Wheeler commented. "Our continued enhancement of our purpose build Pharmaceutical Service Depot network establishes Marken as the clear choice for innovative global clinical supply chain solutions."

Marken the premium provider of life science logistics solutions reinforces its commitment to the Clinical Trial Distribution (CTD) business by accelerating the creation of their global network of Clinical Trial Depots.  The company plans to expand its current network of depots to 12 fully owned and operated facilities in 2012 and is supported by an extensive network of third party service providers.

Andrea will be based in the new Marken Berlin office which is scheduled to begin operation in the first quarter of 2012.

About Marken
Marken is the leading global clinical supply chain service provider dedicated to the pharmaceutical and life sciences industries, supporting over 6,000 investigator sites in more than 100 countries. With decades of experience in the logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection; Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Unveils New Japan Office
2. Marken Rapidly Responds to Global Supply Chain Security Measures
3. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
4. Marken Announces Appointment of Christopher OConnell as New Chief Financial Officer
5. Marken Announces Its New Logistics Operating System: Maestro™
6. Marken Appoints New Head of Global Quality Assurance
7. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
8. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
9. Pepscan Therapeutics Strengthens Management Team
10. Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering
11. Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , 22. März 2017   VWR ... weltweit tätige Anbieter von Produkten und Dienstleistungen ... Erwerb von EPL Archives Inc. bekannt, eines ... Kunden im kompletten Zyklus regulierter Forschung, Entwicklung ... Proben, Speicherung von Dokumenten und Zusatzdienstleistungen zur ...
(Date:3/22/2017)... March 22, 2017 TapImmune, Inc. ... in the development of innovative peptide and gene-based ... disease, today announced that it will participate in ... Dr. Glynn Wilson , Chairman and CEO ... company,s business, clinical pipeline and partnering opportunities for ...
(Date:3/22/2017)... March 22, 2017 A new independent ... is the proven ultraviolet-C (UV-C) disinfection solution of ... (HAIs). Published in the March ... Control , the peer-reviewed study of UV-C disinfection ... Vancouver General Hospital and Rochester General Hospital. According ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... 2017 , ... The Leaders Engaged on Alzheimer’s Disease ... in opposition to the President’s Fiscal Year 2018 Federal Budget Blueprint . ... for the most vulnerable among us. , The proposed budget would cut $15.1 ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... customizable coding audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance Institute ... and accelerates the coding audit process for all medical chart types with a ...
(Date:3/23/2017)... ... 2017 , ... Ogden Clinic, the largest multi-specialty group in ... to expand its focus on patient care by providing an advanced check-in and ... Ogden Clinic, we are working to become a different type of provider, one ...
(Date:3/22/2017)... ... ... Death anxiety is unconscious and needs understanding and non-judgmental support in a loving ... book titled “ As Good as Goodbyes Get ” (published by Balboa Press AU), ... experiencing at the bedside of patients who were dying. The book centers about questions ...
(Date:3/22/2017)... ... March 22, 2017 , ... The American Society for ... (PA) form for prescribers to improve patients’ access to the revolutionary therapy for ... as part of the article entitled “PCSK9 Inhibitor Access Barriers: Issues and ...
Breaking Medicine News(10 mins):